OSSERVAZIONI SULL'USO DI UN ESTROPROGESTINICO "CONVENZIONALE" A BASSO DOSAGGIO SU DONNE IN PRE-MENOPAUSA E MENOPAUSA = OBSERVATIONS SUR L'EMPLOI D'UN OESTRO-PROGESTINIQUE "CONVENTIONNEL" A DOSES FAIBLES CHEZ DES FEMMES EN PERIODE DE PREMENOPAUSE OU DE MENOPAUSEBERGHELLA A.1976; MINERVA GINECOL.; ITAL.; DA. 1976; VOL. 28; NO 5; PP. 456-457; ABS. ANGL.; BIBL. 9 REF.Article

IL CONTROLLO COSTANTE DEL PESO NELLA PREVENZIONE DELL' EPH GESTOSI = CONTROLE DU POIDS AU COURS DE LA GESTATION POUR LA PREVENTION DE LA TOXEMIE GRAVIDIQUEBERGHELLA A.1980; MINERVA GINECOL.; ISSN 0026-4784; ITA; DA. 1980; VOL. 32; NO 7-8; PP. 605-608; ABS. ENG; BIBL. 13 REF.Article

Simultaneous measurement of soluble carcinoembryonic antigen and the tissue inhibitor of metalloproteinase TIMP1 serum levels for use as markers of pre-invasive to invasive colorectal cancerPELLEGRINI, P; CONTASTA, I; BERGHELLA, A. M et al.Cancer immunology and immunotherapy. 2000, Vol 49, Num 7, pp 388-394, issn 0340-7004Article

IL-10 and sIL-2R serum levels as possible peripheral blood prognostic markers in the passage from adenoma to colorectal cancerBERGHELLA, A. M; PELLEGRINI, P; DEL BEATO, T et al.Cancer biotherapy & radiopharmaceuticals. 1997, Vol 12, Num 4, pp 265-272, issn 1084-9785Article

Bcl-2 and drugs used in the treatment of cancer : New strategies of biotherapy which should not be underestimatedBERGHELLA, A. M; PELLEGRINI, P; CONTASTA, I et al.Cancer biotherapy & radiopharmaceuticals. 1998, Vol 13, Num 4, pp 225-237, issn 1084-9785Conference Paper

Immunological directives for biotherapy improvement in the treatment of colorectal cancerPELLEGRINI, P; BERGHELLA, A. M; DEL BEATO, T et al.Cancer biotherapy & radiopharmaceuticals. 1996, Vol 11, Num 2, pp 113-118, issn 1084-9785Article

The sCEA molecule suppressive role in NK and TH1 cell functions in colorectal cancerPELLEGRINI, P; BERGHELLA, A. M; DEL BEATO, T et al.Cancer biotherapy & radiopharmaceuticals. 1997, Vol 12, Num 4, pp 257-264, issn 1084-9785Article

Prognostic significance of immunological evaluation in colorectal cancerBERGHELLA, A. M; PELLEGRINI, P; DEL BEATO, T et al.Cancer biotherapy & radiopharmaceuticals. 1996, Vol 11, Num 6, pp 355-361, issn 1084-9785Article

Detection of circulating ICAM-1 and soluble IL-2 receptor in serum of colorectal cancer patientsPIANCATELLI, D; PELLEGRINI, P; BERGHELLA, A. M et al.International journal of immunotherapy. 1994, Vol 10, Num 1, pp 15-20, issn 0255-9625Article

Relationships between the activity of MMP1/TIMP1 enzymes and the TH1/TH2 cytokine networkCONTASTA, I; BERGHELLA, A. M; PELLEGRINI, P et al.Cancer biotherapy & radiopharmaceuticals. 1999, Vol 14, Num 6, pp 465-475, issn 1084-9785Article

The TH1 and TH2 cytokine network in healthy subjects : Suggestions for experimental studies to create prognostic and diagnostic indices for biotherapeutic treatmentsPELLEGRINI, P; CONTASTA, I; BERGHELLA, A. M et al.Cancer biotherapy & radiopharmaceuticals. 2000, Vol 15, Num 3, pp 267-278, issn 1084-9785Article

The significance of an increase in soluble interleukin-2 receptor level in colorectal cancer and its biological regulating role in the physiological switching of the immune response cytokine network from TH1 to TH2 and backBERGHELLA, A. M; PELLEGRINI, P; DEL BEATO, T et al.Cancer immunology and immunotherapy. 1998, Vol 45, Num 5, pp 241-249, issn 0340-7004Article

Disregulation in TH1 and TH2 subsets of CD4⁺ T cells in peripheral blood of colorectal cancer patients and involvement in cancer establishment and progressionPELLEGRINI, P; BERGHELLA, A. M; DEL BEATO, T et al.Cancer immunology and immunotherapy. 1996, Vol 42, Num 1, pp 1-8, issn 0340-7004Article

Immunological implications of alterations in the c-Ki-ras and p53 genes in the stepwise progression of colorectal cancer : Indications for the improvement of prognosis, biotherapy treatment and tumor biology understandingCONTASTA, I; PELLEGRINI, P; BERGHELLA, A. M et al.Cancer biotherapy & radiopharmaceuticals. 1997, Vol 12, Num 6, pp 385-393, issn 1084-9785Conference Paper